- DKK194.11bn
- DKK214.83bn
- DKK24.50bn
- 74
- 11
- 61
- 44
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 33.35 | ||
| PEG Ratio (f) | 2.98 | ||
| EPS Growth (f) | 12.61% | ||
| Dividend Yield (f) | 2.53% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 12.83 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 45.34 | ||
| Price to Sales | 7.76 | ||
| EV to EBITDA | 27.08 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 22.97% | ||
| Return on Equity | 46.3% | ||
| Operating Margin | 27.27% | ||
Financial Summary
| Year End 30th Sep | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | DKKm | 17,939 | 18,544 | 19,426 | 22,579 | 24,500 | 27,326.42 | 29,708.33 | 8.29% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +8.16 | -0.5 | +18.71 | +1.96 | -5.66 | +4.03 | +18.69 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The Company supplies products to hospitals, institutions as well as wholesalers and pharmacies.
Directors
- Lars Rasmussen CHM (62)
- Kristian Villumsen PRE (51)
- Niels Louis-Hansen VCH (74)
- Anders Lonning-Skovgaard CFO (48)
- Nicolai Andersen EVP
- Paul Marcun EVP (54)
- Allan Rasmussen EVP (53)
- Camilla Moehl SVP
- Thomas Barfod DRC (51)
- Nikolaj Kyhe Gundersen DRC (52)
- Roland Vendelbo Pedersen DRC (59)
- Carsten Hellmann IND (57)
- Birgitte Nielsen IND (58)
- Jette Nygaard-Andersen IND (53)
- Marianne Wiinholt IND (56)
- Last Annual
- September 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- September 4th, 1957
- Public Since
- January 1st, 1983
- No. of Shareholders
- 59,299
- No. of Employees
- 15,751
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
OMX Nordic Exchange - Copenhagen- Shares in Issue
- 224,824,825
- Address
- Holtedam 1-3, HUMLEBAEK, 3050
- Web
- https://www.coloplast.dk/
- Phone
- +45 null49111111
- Contact
- Aleksandra Dimovska
- Auditors
- PricewaterhouseCoopers
Upcoming Events for COLO B
Q2 2024 Coloplast A/S Earnings Call
Coloplast A/S Meet the Management Event
Q3 2024 Coloplast A/S Earnings Release
Q3 2024 Coloplast A/S Earnings Call
Similar to COLO B
Ambu A/S
OMX Nordic Exchange - Copenhagen
Bactiquant A/S
OMX Nordic Exchange - Copenhagen
BioPorto A/S
OMX Nordic Exchange - Copenhagen
ChemoMetec A/S
OMX Nordic Exchange - Copenhagen
Demant A/S
OMX Nordic Exchange - Copenhagen
FAQ
What is the Coloplast A/S share price?
As of Today at 01:05 UTC, shares in Coloplast A/S are trading at DKK863.40. This share price information is delayed by 15 minutes.
How has the Coloplast A/S share price performed this year?
Shares in Coloplast A/S last closed at DKK863.40 and the price had moved by -10.6% over the past 365 days. In terms of relative price strength the Coloplast A/S share price has underperformed the FTSE Global All Cap Index by -18.1% over the past year.
What are the analyst and broker recommendations for Coloplast A/S?
The overall consensus recommendation for Coloplast A/S is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Coloplast A/S dividend yield?
The Coloplast A/S dividend yield is 2.43% based on the trailing twelve month period.
Does Coloplast A/S pay a dividend?
Last year, Coloplast A/S paid a total dividend of DKK21.00, and it currently has a trailing dividend yield of 2.43%. We do not have any data on when Coloplast A/S is to next pay dividends.
When does Coloplast A/S next pay dividends?
We do not have data on when Coloplast A/S is to next pay dividends. The historic dividend yield on Coloplast A/S shares is currently 2.43%.
How do I buy Coloplast A/S shares?
To buy shares in Coloplast A/S you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Coloplast A/S?
As of the previous close price of DKK863.40, shares in Coloplast A/S had a market capitalisation of DKK194.11bn.
Where are Coloplast A/S shares listed?
Here are the trading details for Coloplast A/S:
- Country of listing: Denmark
- Exchange: CPH
- Ticker Symbol: COLO B
What kind of share is Coloplast A/S?
Based on an overall assessment of its quality, value and momentum Coloplast A/S is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Coloplast A/S share price forecast for 2024?
The analyst consensus target price for shares in Coloplast A/S is DKK940.00. That is 8.87% above the last closing price of DKK863.40.
Analysts covering Coloplast A/S currently have a consensus Earnings Per Share (EPS) forecast of DKK23.37 for the next financial year.
What is the trend in the Coloplast A/S share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Coloplast A/S. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +2%.
As of the last closing price of DKK863.40, shares in Coloplast A/S were trading +6.26% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Coloplast A/S PE Ratio?
The Coloplast A/S PE ratio based on its reported earnings over the past 12 months is 33.35. The shares last closed at DKK863.40.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Coloplast A/S?
Coloplast A/S' management team is headed by:
- Lars Rasmussen - CHM
- Kristian Villumsen - PRE
- Niels Louis-Hansen - VCH
- Anders Lonning-Skovgaard - CFO
- Nicolai Andersen - EVP
- Paul Marcun - EVP
- Allan Rasmussen - EVP
- Camilla Moehl - SVP
- Thomas Barfod - DRC
- Nikolaj Kyhe Gundersen - DRC
- Roland Vendelbo Pedersen - DRC
- Carsten Hellmann - IND
- Birgitte Nielsen - IND
- Jette Nygaard-Andersen - IND
- Marianne Wiinholt - IND